The amyloid β (Aβ), tau, α-synuclein, and superoxide dismutase 1 were previously quantified in EVs in AD, PD, and ALS, and in several studies the correlation of their levels with the disease stages were found [51,60,64,70,71,72,73,74]. This evidence concerns the gene MAPT and Alzheimer disease.